How Long Does Urinary Continence Last After Treatment with Intravaginal CO Laser and Microablative Radiofrequency? A Four-Year Follow-up of a Multi-arm Randomized Clinical Trial (LARF-arm3)

Overview

Journal Int Urogynecol J

Publisher Springer

Specialties Gynecology & Obstetrics
Urology

Date 2025 Feb 13

PMID 39945802

Authors

Ana Silvia Seki

Ana Maria Homem de Mello Bianchi-Ferraro

Tatiana Carvalho Sousa Bonetti

Eliana Suelotto Machado Fonseca

Marair Gracio Ferreira Sartori

Zsuzsanna Ilona Katalin de Jarmy-Di Bella

Affiliations

Soon will be listed here.

Abstract

Introduction And Hypothesis: CO laser (LS) and microablative radiofrequency (RF) are outpatient options for stress urinary incontinence (SUI) treatment. The aim of this study was to evaluate the lasting effects of SUI treatment using intravaginal CO LS and microablative RF.

Methods: This is a long-term follow-up of a prospective double-blind multi-arm randomized controlled trial, involving women with pure or predominant SUI. Participants received three monthly sessions of LS, RF, or were part of a sham control group (SCT) and were followed up, every 6 months, for 48 months to assess continence rates, defined by the composed outcome: no symptoms, negative stress test, and negative 7-day voiding diary.

Results: One hundred and thirty-nine women were eligible and randomized into the three groups. One hundred and fourteen participants concluded the treatment protocol. The women's mean age was 50.4 (± 9.5) years. The results showed that both LS and RF treatments led to a mean duration of urinary continence of 26.7 months and 24.58 months respectively, compared with 8.21 months in the SCT group. No major complications were observed.

Conclusion: Although the continence rates declined over the time, more than 50% of women in perimenopause, with mild to moderate SUI, pure or predominant SUI, remained without complaints of SUI for at least 24 months after LS or RF application sessions, with no major complications reported.

References

Itkonen Freitas A, Rahkola-Soisalo P, Mikkola T, Mentula M . Current treatments for female primary stress urinary incontinence. Climacteric. 2019; 22(3):263-269. DOI: 10.1080/13697137.2019.1568404. View

Lavelle E, Zyczynski H . Stress Urinary Incontinence: Comparative Efficacy Trials. Obstet Gynecol Clin North Am. 2016; 43(1):45-57. DOI: 10.1016/j.ogc.2015.10.009. View

Lim R, Liong M, Leong W, Khan N, Yuen K . Effect of Stress Urinary Incontinence on the Sexual Function of Couples and the Quality of Life of Patients. J Urol. 2016; 196(1):153-8. DOI: 10.1016/j.juro.2016.01.090. View

Fusco F, Abdel-Fattah M, Chapple C, Creta M, La Falce S, Waltregny D . Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence. Eur Urol. 2017; 72(4):567-591. DOI: 10.1016/j.eururo.2017.04.026. View

Guillot-Tantay C, Van Kerrebroeck P, Chartier-Kastler E, Dechartres A, Tubach F . Long-term Safety of Synthetic Midurethral Sling Implantation for the Treatment of Stress Urinary Incontinence in Adult Women: A Systematic Review. Eur Urol Open Sci. 2023; 54:10-19. PMC: 10276216. DOI: 10.1016/j.euros.2023.05.013. View

Slongo H, Lunardi A, Riccetto C, Machado H, Juliato C . Microablative radiofrequency versus pelvic floor muscle training for stress urinary incontinence: a randomized controlled trial. Int Urogynecol J. 2021; 33(1):53-64. DOI: 10.1007/s00192-021-04758-2. View

Rocha-Rangel S, Pereira G, Juliato C, Brito L . Laser and Pelvic Floor Muscle Training for Urinary Incontinence: A Randomized Clinical Trial. Urogynecology (Phila). 2024; . DOI: 10.1097/SPV.0000000000001516. View

da Fonseca L, Giarreta F, Peterson T, Locali P, Baracat E, Ferreira E . A randomized trial comparing vaginal laser therapy and pelvic floor physical therapy for treating women with stress urinary incontinence. Neurourol Urodyn. 2023; 42(7):1445-1454. DOI: 10.1002/nau.25244. View

Hafidh B, Baradwan S, Latifah H, Gari A, Sabban H, Abduljabbar H . CO laser therapy for management of stress urinary incontinence in women: a systematic review and meta-analysis. Ther Adv Urol. 2023; 15:17562872231210216. PMC: 10638870. DOI: 10.1177/17562872231210216. View

10.

Dabaja H, Lauterbach R, Matanes E, Gruenwald I, Lowenstein L . The safety and efficacy of CO laser in the treatment of stress urinary incontinence. Int Urogynecol J. 2019; 31(8):1691-1696. DOI: 10.1007/s00192-019-04204-4. View

11.

Behnia-Willison F, Nguyen T, Mohamadi B, Vancaillie T, Lam A, Willison N . Fractional CO laser for treatment of stress urinary incontinence. Eur J Obstet Gynecol Reprod Biol X. 2019; 1:100004. PMC: 6683978. DOI: 10.1016/j.eurox.2019.100004. View

12.

Alcalay M, Ben Ami M, Greenshpun A, Hagay Z, Schiff E . Fractional-Pixel CO Laser Treatment in Patients With Urodynamic Stress Urinary Incontinence: 1-Year Follow-Up. Lasers Surg Med. 2020; 53(7):960-967. DOI: 10.1002/lsm.23329. View

13.

Gambacciani M, Levancini M, Russo E, Vacca L, Simoncini T, Cervigni M . Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric. 2018; 21(2):148-152. DOI: 10.1080/13697137.2018.1436538. View

14.

Seki A, Bianchi-Ferraro A, Fonseca E, Sartori M, Girao M, Jarmy-Di Bella Z . CO Laser and radiofrequency compared to a sham control group in treatment of stress urinary incontinence (LARF study arm 3). A randomized controlled trial. Int Urogynecol J. 2022; 33(12):3535-3542. DOI: 10.1007/s00192-022-05091-y. View

15.

Digesu G, Tailor V, Preti M, Vieira-Baptista P, Tarcan T, Stockdale C . The energy based devices for vaginal "rejuvenation," urinary incontinence, vaginal cosmetic procedures, and other vulvo-vaginal disorders: An international multidisciplinary expert panel opinion. Neurourol Urodyn. 2019; 38(3):1005-1008. DOI: 10.1002/nau.23927. View

16.

Giarenis I, Tsiapakidou S, Zacche M, Mukhopadhyay S, Mahmood T . European Board and College of Obstetrics and Gynaecology (EBCOG) position statement on the use of laser vaginal devices for treatment of genitourinary syndrome of menopause, vaginal laxity, pelvic organ prolapse and stress urinary incontinence. Eur J Obstet Gynecol Reprod Biol. 2024; 299:342-344. DOI: 10.1016/j.ejogrb.2024.05.021. View

17.

Krhut J, Zachoval R, Smith P, Rosier P, Valansky L, Martan A . Pad weight testing in the evaluation of urinary incontinence. Neurourol Urodyn. 2013; 33(5):507-10. DOI: 10.1002/nau.22436. View

18.

Ghaderi F, Oskouei A . Physiotherapy for women with stress urinary incontinence: a review article. J Phys Ther Sci. 2014; 26(9):1493-9. PMC: 4175265. DOI: 10.1589/jpts.26.1493. View

19.

Dumoulin C, Cacciari L, Hay-Smith E . Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018; 10:CD005654. PMC: 6516955. DOI: 10.1002/14651858.CD005654.pub4. View

20.

Malek J, Kissane L, Martin K, Meyer I, Powell T, Richter H . Short-, mid-, and long-term incontinence outcomes in women undergoing mid-urethral sling procedures: a retrospective cohort study. Int Urogynecol J. 2020; 32(3):609-614. PMC: 7749834. DOI: 10.1007/s00192-020-04393-3. View